SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE

被引：132

作者：

BRAUN, A ^{[1
]}

FABBRINI, G ^{[1
]}

MOURADIAN, MM ^{[1
]}

SERRATI, C ^{[1
]}

BARONE, P ^{[1
]}

CHASE, TN ^{[1
]}

机构：

[1] NINCDS,EXPTL THERAPEUT BRANCH,BLDG 10,ROOM 5C103,BETHESDA,MD 20892

来源：

JOURNAL OF NEURAL TRANSMISSION | 1987年 / 68卷 / 1-2期

关键词：

D O I：

10.1007/BF01244638

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：41 / 50

页数：10

共 50 条

[1] D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE
BRAUN, AR
FABBRINI, G
MOURADIAN, MM
BARONE, P
CHASE, TN
[J]. NEUROLOGY, 1986, 36 (04) : 246 - 246
[2] PRAMIPEXOLE - A DOPAMINE-RECEPTOR AGONIST FOR TREATMENT OF PARKINSONS-DISEASE
MIERAU, J
[J]. CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S195 - S206
[3] DOPAMINE D-1 RECEPTOR AND CYCLIC AMP-DEPENDENT PHOSPHORYLATION IN PARKINSONS-DISEASE
CASH, R
RAISMAN, R
PLOSKA, A
AGID, Y
[J]. JOURNAL OF NEUROCHEMISTRY, 1987, 49 (04) : 1075 - 1083
[4] THE DOPAMINE AGONIST LISURIDE IN THE TREATMENT OF PARKINSONS-DISEASE
MADEJA, UD
[J]. ACTA HISTOCHEMICA, 1992, : 25 - 31
[5] A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE
ASIN, KE
NIKKEL, A
BEDNARZ, L
DOMINO, EF
SHIOSAKI, K
[J]. FASEB JOURNAL, 1995, 9 (03): : A395 - A395
[6] LISURIDE, A DOPAMINE AGONIST IN THE TREATMENT OF EARLY PARKINSONS-DISEASE
RINNE, UK
[J]. NEUROLOGY, 1989, 39 (03) : 336 - 339
[7] PIRIBEDIL, A DOPAMINE AGONIST, IN PARKINSONS-DISEASE
SWEET, RD
WASTERLAIN, CG
MCDOWELL, FH
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (06) : 1077 - 1082
[8] EARLY COMBINATION OF DOPAMINE AGONIST AND LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
RINNE, UK
[J]. MOUNT SINAI JOURNAL OF MEDICINE, 1988, 55 (02): : 138 - 141
[9] TREATMENT OF PARKINSONS-DISEASE WITH THE PARTIAL DOPAMINE AGONIST EMD 49980
BRAVI, D
DAVIS, TL
MOURADIAN, MM
CHASE, TN
[J]. MOVEMENT DISORDERS, 1993, 8 (02) : 195 - 197
[10] DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
CHASE, TN
METMAN, LV
BRAVI, D
ROBERTS, JW
SIBLEY, DR
MOURADIAN, MM
[J]. CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S207 - S215

← 1 2 3 4 5 →